CDK6 further facilitates cancer cell survival of FLT3-ITD+ AML by directly activating transcription of the proviral integration site for Moloney murine leukemia virus 1 (PIM1), another important leukemogenic driver. This evidence concerns the gene CDK6 and acute myeloid leukemia.